News

Quality of Dyspnea Directs Diagnosis, Management

Publish date: February 21, 2012

 

EXPERT ANALYSIS FROM A MEETING ON ALLERGY AND RESPIRATORY DISEASES

Dr. Good disclosed serving as an investigator and speaker for Genentech and as a speaker for GlaxoSmithKline and Merck.

Pages

Recommended Reading

No Lung Damage Seen in Typical Marijuana Smokers
MDedge Internal Medicine
Local and Regional Lung Allocation Systems Conflict
MDedge Internal Medicine
Melatonin May Normalize Night Owl Sleep Schedules
MDedge Internal Medicine
Teach Insomniacs That Beds Are for Sleeping
MDedge Internal Medicine
Frequent Respiratory Infections? Rule Out Bronchiectasis
MDedge Internal Medicine
Anticipate Mycobacterial Lung Disease in Anti-TNF Users
MDedge Internal Medicine
ARDS Outcome Linked to Oxygenation at 48 Hours
MDedge Internal Medicine
Prophylactic Semuloparin Cuts Rate of VTE in Cancer Patients
MDedge Internal Medicine
Extended-Release Gabapentin an Option for Augmentation in RLS
MDedge Internal Medicine
Early Strides Made in Personalized Refractory Asthma Care
MDedge Internal Medicine